ANN ARBOUR, Mich.–(BUSINESS WIRE)–ENDRA Life Sciences Inc. (NASDAQ: NDRA), a pioneer in enhanced ultrasound technologies, announces that management will present a company overview at the HC Wainwright Global Investment Conference to be held May 23-26, 2022 in Miami Beach and will be hosting virtual one-on-one meetings. A webcast of the presentation will be available on demand beginning May 24, 2022 at 7:00 a.m. EST on the Investors section of the ENDRA website.
About ENDRA Life Sciences Inc.
ENDRA Life Sciences is the pioneer of enhanced thermo-acoustic ultrasound (TAEUS®), a revolutionary technology being developed to visualize tissue like MRI, but at 1/50and cost and at the point of patient care. TAEU® is designed to work in concert with 400,000 cart-based ultrasound systems currently in use around the world. TAEU® initially focused on measuring fat in the liver as a way to assess and monitor non-alcoholic fatty liver disease (NAFLD) and inflammation (NASH), chronic liver conditions that affect more than one billion people worldwide. the world and for which there are no practical diagnostic tools. Beyond the liver, ENDRA is exploring several other clinical applications of TAEUS®, including visualization of tissue temperature during energy surgeries. For more information, please visit www.endrainc.com.